Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate
article
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study compared the efficacy of a combined oral contraceptive containing ethinylestradiol/dienogest for acne treatment against placebo and ethinylestradiol/cyproterone acetate.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (21)
- Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception via openalex
- Effect of dienogest-containing oral contraceptives on lipid metabolism via openalex
- New progestagens for contraceptive use via openalex
- The effects of Valette on skin and hair: a post-marketing surveillance study. via openalex
- THE EFFECTS OF VALETTE® ON SKIN AND HAIR: A POST‐MARKETING SURVEILLANCE STUDY via openalex
- W1558720625 via openalex
- W2424948565 via openalex
- W4285719527 via openalex
- W6606923416 via openalex
- W6633119876 via openalex
- W6717335893 via openalex
- W6718493757 via openalex
- W6720533243 via openalex
- W6725219575 via openalex
- doi:10.1159/000017849 via openalex
- doi:10.1016/s0190-9622(08)80076-x via openalex
- doi:10.1016/j.contraception.2005.07.010 via openalex
- doi:10.1001/archderm.135.9.1101 via openalex
- doi:10.1111/j.1365-2133.2004.05696.x via openalex
- W164693521 via openalex
- W169351428 via openalex
Cited by (8)
- A prospective randomized trial comparing two different oral contraceptive containing dienogest or drospirenone for the treatment of hirsutism in policystic ovarian syndrome 2020
- Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age 2018
- Clinical behavior of a cohort of adult women with facial acne treated with combined oral contraceptive: ethinylestradiol 20 µg/dienogest 2 mg 2017
- Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone 2017
- Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study 2013
- Ethinylestradiol/Dienogest in Oral Contraception 2010
- Efficacy of a combined oral contraceptive containing 0.030mg ethinylestradiol/2mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035mg ethinylestradiol/2mg cyproterone acetate 2010
- Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial 2009
Source provenance
- openalex
- last seen: 2026-05-11T06:37:04.871248+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK